neostigmine has been researched along with Anorectal Diseases in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Dudi-Venkata, NN | 1 |
Kroon, HM | 1 |
Bedrikovetski, S | 1 |
Moore, JW | 1 |
Sammour, T | 1 |
Jennings, PJ | 1 |
1 review available for neostigmine and Anorectal Diseases
Article | Year |
---|---|
Systematic scoping review of enhanced recovery protocol recommendations targeting return of gastrointestinal function after colorectal surgery.
Topics: Bisacodyl; Chewing Gum; Colonic Diseases; Humans; Ileus; Lactulose; Neostigmine; Piperidines; Postop | 2020 |
1 other study available for neostigmine and Anorectal Diseases
Article | Year |
---|---|
Megarectum and megacolon in adolescents and young adults: results of treatment at St. Mark's Hospital.
Topics: Adolescent; Adult; Colectomy; Female; Humans; Magnesium Sulfate; Male; Megacolon; Neostigmine; Recta | 1967 |